Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 2Breast Neoplasms 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sexually Transmitted Diseases 1Ovarian Cysts 1Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1High-grade Anal Intraepithelial Neoplasia 1HIV Infections 1Endometriosis 1Condylomata Acuminata 1Benign Ovarian Tumor 1Anus Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 15Vaccines, Synthetic 10Papillomavirus Vaccines 7Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3human papillomavirus vaccine, L1 type 16, 18 2green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1PRA1 protein, Candida albicans 1Omiganan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Condylomata Acuminata × Electrocoagulation × Clear all
NCT02520986 2025-08-19

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Zydolab - Institute of Cytology and Immune Cytochemistry

Phase NA Recruiting
114 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡